First of all it was one letter. Not letterS - so that's completely misleading on it's own. Not surprised. Second, it was a process letter - so it did not, and has not disrupted any of Elites day to day business. And third, the letter was so minimal in severity, it didn't even warrant appearing on the FDA site: